7 results
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
/HRS Guidelines ... #Management #Pharm ... #EM #IM #Cardiology ... #Afib #Common # ... Medications #RateControl
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
VHD Guidelines) ... anticoagulants (DOACs ... #Management #Cardiology ... #INR #Target #DOAC ... #Table #Replacement
Anticoagulation for Atrial Fibrillation - CHA2DS2-VASc

I always tell my students, one of the first thing you
Both guidelines ... recommend DOAC over ... least ONE non-sex risk ... AtrialFibrillation #AFib ... CHADS2VASC #Score #Management
Anticoagulant Therapy after PCI (patients with AFib)
Dual-Therapy Preferred:
 • Triple therapy = increased bleeding
(patients with AFib ... - Bleeding risk ... due to use of DOAC ... Triple #therapy #anticoagulation ... #management #cardiology
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
cardiovascular risk ... typically needed • DOACs ... Absolute warfarin indications ... #diagnosis #management ... #cardiology
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... Stable patients ... Anticoagulation ... one post op Cardiology ... medical and surgical management
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Avoid Warfarin and DOAC ... Delivery • Stable ... suggest prophylactic anticoagulation ... e.g., <50%), ESC guidelines ... #cardiology #treatment